Literature DB >> 23946757

Late-onset distant metastatic upper urinary tract urothelial carcinoma mimicking lung adenocarcinoma.

Jun-Hyeok Lim1, Sang Hoon Jeon, Jeong Min Lee, Lucia Kim, Jae Hwa Cho, Jeong-Seon Ryu, Seung Min Kwak, Hong Lyeol Lee, Hae-Seong Nam.   

Abstract

Urothelial carcinomas (UCs) can occur in the upper urinary tract or lower urinary tract. Upper urinary tract urothelial carcinoma (UUT-UC) is relatively a rare disease and accounts for only about 5% of UC cases. Sporadic cases of late-onset metastasis, associated with UC of the bladder, have occasionally been reported. In contrast, no late-onset distant metastatic UUT-UC without local recurrence has, to the best of our knowledge, been reported in the English literature. We report an extremely rare case of distant metastatic UC, mimicking lung adenocarcinoma that originated from UUT-UC 12 years previously.

Entities:  

Keywords:  Adenocarcinoma of Lung; Carcinoma; Urinary Tract; Urothelium

Year:  2013        PMID: 23946757      PMCID: PMC3741472          DOI: 10.4046/trd.2013.75.1.32

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  14 in total

Review 1.  Upper-tract transitional cell carcinoma.

Authors:  E R Tawfiek; D H Bagley
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

2.  European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.

Authors:  Morgan Rouprêt; Richard Zigeuner; Juan Palou; Andreas Boehle; Eero Kaasinen; Richard Sylvester; Marko Babjuk; Willem Oosterlinck
Journal:  Eur Urol       Date:  2011-01-14       Impact factor: 20.096

3.  Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

Authors:  Sanjay Mukhopadhyay; Anna-Luise A Katzenstein
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

Review 4.  Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.

Authors:  Matthew D Galsky; Noah M Hahn; Jonathan Rosenberg; Guru Sonpavde; Thomas Hutson; William K Oh; Robert Dreicer; Nicholas Vogelzang; Cora N Sternberg; Dean F Bajorin; Joaquim Bellmunt
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

5.  Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.

Authors:  Lakshmi P Kunju; Rohit Mehra; Matthew Snyder; Rajal B Shah
Journal:  Am J Clin Pathol       Date:  2006-05       Impact factor: 2.493

6.  Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.

Authors:  O Kaufmann; E Fietze; J Mengs; M Dietel
Journal:  Am J Clin Pathol       Date:  2001-12       Impact factor: 2.493

Review 7.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 8.  Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.

Authors:  Mahul B Amin
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

Review 9.  The many faces of urothelial carcinoma: an update with an emphasis on recently described variants.

Authors:  Priya Nigwekar; Mahul B Amin
Journal:  Adv Anat Pathol       Date:  2008-07       Impact factor: 3.875

Review 10.  Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature.

Authors:  David W Dougherty; Victoria K Gonsorcik; Lewis E Harpster; J C Trussell; Joseph J Drabick
Journal:  Urology       Date:  2008-04-18       Impact factor: 2.649

View more
  1 in total

1.  Pulmonary metastasis from urothelial carcinoma of the upper urinary tract 29 years after nephrectomy.

Authors:  Koji Kawaguchi; Toshiki Okasaka; Takayuki Fukui; Koichi Fukumoto; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Kohei Yokoi
Journal:  Surg Case Rep       Date:  2017-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.